When to Refer a Patient to GI for Iron Deficiency Anemia
All men and postmenopausal women with newly diagnosed IDA should be referred to gastroenterology for bidirectional endoscopy (gastroscopy and colonoscopy), as approximately one-third have underlying GI pathology including malignancy. 1
Immediate Referral Criteria
High-Priority Populations (Strong Recommendation)
- All men with confirmed IDA - regardless of age or symptoms 1, 2
- All postmenopausal women with confirmed IDA - regardless of age or symptoms 1, 2
- Premenopausal women with IDA when any of the following apply:
Non-Anemic Iron Deficiency (NAID)
The threshold for GI investigation should be low in the following groups with iron deficiency but normal hemoglobin 1:
- Men of any age
- Postmenopausal women
- Anyone with GI symptoms
- Anyone with family history of GI pathology
Note: GI investigation is generally not warranted in premenopausal women with NAID unless other risk factors are present, as the cancer risk is very low in this population 1.
Diagnostic Confirmation Before Referral
Iron Studies Required
Before referring, confirm iron deficiency using 1:
- Ferritin <45 μg/L (optimal cutoff with 92% specificity) 1, 2
- Ferritin <15 μg/L is highly specific (99% specificity) 1
- In inflammatory conditions, ferritin up to 100 μg/L may still represent iron deficiency; consider transferrin saturation 1
- Ferritin >150 μg/L essentially excludes absolute iron deficiency, even with inflammation 1
Initial Workup to Complete Before Referral
The following should be performed prior to or concurrent with GI referral 1:
- Urinalysis or urine microscopy (to exclude urinary blood loss)
- Celiac disease serologic screening (found in 3-5% of IDA cases) 1
- Hemoglobin, mean cell volume, and complete blood count
- Consider H. pylori testing (non-invasive) 2, 3
Special Populations Requiring Modified Approach
Premenopausal Women
The AGA suggests bidirectional endoscopy over iron replacement alone, but this is a conditional recommendation 2, 3. Patients who are young with plausible menstrual causes and who place high value on avoiding endoscopy risks may reasonably choose initial iron replacement with monitoring 2, 3. However, proceed with endoscopy if:
- Inadequate response to iron therapy (Hb rise <10 g/L within 2 weeks) 1
- Recurrent IDA after initial correction 1
- Any GI symptoms or family history 1
Patients with Inflammatory Conditions
In patients with inflammatory bowel disease, chronic kidney disease, or other inflammatory conditions 1:
- Use ferritin cutoff of 45 μg/L rather than 15 μg/L 1
- Consider transferrin saturation if ferritin appears falsely normal 1
- Ferritin up to 100 μg/L may still indicate iron deficiency in active inflammation 1
Post-GI Surgery Patients
Patients with history of gastric bypass, bariatric surgery, or small bowel resection commonly develop IDA 1. However, new presentations of IDA should not preclude searching for other causes - still refer for endoscopy to exclude concurrent pathology 1.
Timing and Urgency
- Urgent/fast-track referral is indicated for unexplained IDA in at-risk individuals (men and postmenopausal women) due to malignancy risk 1
- Age, sex, hemoglobin concentration, and mean cell volume are independent predictors of GI cancer risk and should inform urgency 1
- The overall cancer detection rate in appropriately referred IDA patients is approximately 9-11% 4, 5
Common Pitfalls to Avoid
Do not refer without confirming iron deficiency - in one study, only 10.8% of 2-week wait referrals met all necessary criteria for IDA diagnosis, with 35/77 inappropriate referrals having no evidence of iron deficiency at all 4. This wastes resources and delays care for appropriate patients.
Do not assume a single cause - while concomitant upper and lower GI lesions are rare, both gastroscopy and colonoscopy should generally be performed in at-risk populations, as upper GI lesions are found in 36% and lower GI lesions in 25% of cases 5.
Do not skip celiac screening - this is found in 3-5% of IDA cases and can be tested serologically or via small bowel biopsy at gastroscopy 1.